114 related articles for article (PubMed ID: 10443854)
1. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
Riondino S; Pignatelli P; Pulcinelli FM; Lenti L; Di Veroli C; Marigliano V; Gazzaniga PP
J Am Geriatr Soc; 1999 Aug; 47(8):943-7. PubMed ID: 10443854
[TBL] [Abstract][Full Text] [Related]
2. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
3. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
Islim IF; Bareford D; Beevers DG
Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
[TBL] [Abstract][Full Text] [Related]
4. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
[TBL] [Abstract][Full Text] [Related]
5. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
[TBL] [Abstract][Full Text] [Related]
6. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
7. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
8. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
Motero Carrasco J
Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
[TBL] [Abstract][Full Text] [Related]
10. Effect of losartan on nocturnal blood pressure in patients with stroke: comparison with angiotensin converting enzyme inhibitor.
Okuguchi T; Osanai T; Fujiwara N; Kato T; Metoki N; Konta Y; Okumura K
Am J Hypertens; 2002 Nov; 15(11):998-1002. PubMed ID: 12441222
[TBL] [Abstract][Full Text] [Related]
11. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
Larochelle P; Haynes B; Maron N; Dugas S
Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
[TBL] [Abstract][Full Text] [Related]
12. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension.
Huang JL; Cheng FC; Chen YT; Ting CT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848
[TBL] [Abstract][Full Text] [Related]
13. [Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy].
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Aschermann M; Horký K
Vnitr Lek; 2002 Aug; 48(8):718-23. PubMed ID: 12425201
[TBL] [Abstract][Full Text] [Related]
14. Use of quinapril in the elderly patient.
Schnaper HW
Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
[TBL] [Abstract][Full Text] [Related]
15. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
16. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
[TBL] [Abstract][Full Text] [Related]
17. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
Manzato E; Capurso A; Crepaldi G
J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
19. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
Larochelle P
Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
[TBL] [Abstract][Full Text] [Related]
20. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
